VANI
Vivani Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.49
+7.19%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.9x
Market Cap
$134.40M
MomentumView details →
1D Return
+7.19%
YTD Return
+19.92%
RSI (14)
58.7
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.9x
Market Cap
$134.40M
RSI (14)
58.7
MomentumView details →
1D Return
+7.19%
YTD Return
+19.92%
SummaryUpdated Jun 1, 2026
Vivani Medical, Inc. (NASDAQ:VANI) is a clinical-stage medical device company founded in 2014 and headquartered in Emeryville, California. The company went public in November 2014 and focuses on developing innovative implantable medical devices to address chronic diseases with significant unmet medical needs. Vivani operates as a pre-revenue company, dedicating its resources to advancing two primary technology platforms through clinical development stages.
Similar companies
Latest newsMore news →
Vivani Medical announced it is preparing to begin human testing of its semaglutide implant in August.51d agoNovo Nordisk signed an agreement with Vivani Medical to evaluate Vivani's experimental NPM-139 implant for continuous semaglutide delivery.55d agoVivani Medical signed an agreement with Novo Nordisk to enable Novo Nordisk to evaluate NPM-139, a semaglutide drug implant for chronic weight management.59d ago